We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Healthcare professionals should complete this form for children whose screening result is presumed positive when giving results.
Form for notifying the newborn blood spot (NBS) screening programme of a cystic fibrosis (CF) diagnosis that was not detected by screening.
Laboratories can use this template to notify a GP or child health records department (CHRD) that a child's blood spot screen for cystic fibrosis (CF) is not complete.
Healthcare professionals should complete this form for children who are carriers of the cystic fibrosis (CF) gene within 24 hours of giving results.
Laboratories can use these templates to notify relevant clinicians of a presumed positive blood spot screening result for cystic fibrosis (CF).
Laboratories can use this form when requesting a repeat immunoreactive trypsinogen (IRT) test if a first blood spot test is inconclusive for cystic fibrosis (CF).
Laboratories can use this template to notify a GP of a child's blood spot screening result of possible carrier of the cystic fibrosis (CF) gene.
You do not need to tell DVLA if you have cystic fibrosis
All healthcare and laboratory professionals involved in NHS newborn blood spot screening should use this process for cystic fibrosis (CF) referrals.
Information for parents to explain what it means to have a positive screening result for carrying the cystic fibrosis (CF) gene.
This document explains the guidelines for laboratories screening newborns for cystic fibrosis (CF) in the UK.
This information explains what a suspected screening result for cystic fibrosis (CF) means.
For the first time, 2- to 5-year-old patients with a certain type of cystic fibrosis could access cystic fibrosis drugs Kaftrio and Kalydeco.
Letter from Martin Campbell, Deputy Director, NHS Finance issued 18 January 2012 re guidance on cystic fibrosis.
You must tell DVLA if you have a brain abscess, cyst or encephalitis - download the correct form to let them know
Information sheet for parents of babies who need a repeat blood spot test for cystic fibrosis.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.